207 Results for "

HCA.

" in MedChemExpress (MCE) Product Catalog:
Products (207)

207 Results for "HCA." in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-B0782
CAS No.: 59-66-5
Acetazolamide is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide has diuretic, antihypertensive and anti-gonococcal activities .
loading...
    loading...
15
15 Publications Verification
Cat. No.: HY-B0782A
CAS No.: 1424-27-7
Acetazolamide sodium is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide sodium has diuretic, antihypertensive and anti-gonococcal activities .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-119222
CAS No.: 862892-90-8
Purity:  99.11%
Target:  

GPR109A

Research Areas:  

Metabolic Disease

GSK256073 is a potent, selective and orally active GPR109A agonist and a long-lasting and non-flushing HCA2 full agonist with a pEC50 of 7.5 (human HCA2). GSK256073 acutely improves glucose homeostasis via inhibition of lipolysis and has the potential for the study of type 2 diabetes mellitus (T2DM)and dyslipidemia . GPR109A: G-protein coupled receptor 109A; HCA2: hydroxy-carboxylic acid receptor 2
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0124
CAS No.: 68291-97-4
Synonyms: AD 810; CI 912
Research Areas:  

Neurological Disease

Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-118467
CAS No.: 3368-13-6
Purity:  99.07%
Synonyms: CL11366
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease Cancer

Benzolamide (CL11366) is a potent carbonic anhydrase (CA) inhibitor, with Kis of 15 nM, 9 nM, 94 nM and 78 nM for hCA I, hCA II, EcoCAγ and VchCAγ, respectively. Benzolamide also inhibits CAS3, with a Ki of 54 nM. Benzolamide can be used for the research of glaucoma and seizures .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-138903
CAS No.: 14857-77-3
Purity:  ≥98.0%
Synonyms: L-HCA
Target:  

iGluR

Research Areas:  

Neurological Disease

L-Homocysteic acid (L-HCA) is an endogenous excitatory amino acid that acts as a NMDA receptor agonist (EC50: 14 μM). L-Homocysteic acid is neurotoxic, and can be used in the research of neurological disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100976
CAS No.: 92933-48-7
Purity:  98.92%
LUF6283 is a potent and orally active HCA(2) partial agonist, with a Ki of 0.55 µM. LUF6283 can achieve the beneficial lipid lowering effect of niacin without producing the unwanted cutaneous flushing side effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108559
CAS No.: 147776-06-5
Purity:  99.30%
Research Areas:  

Inflammation/Immunology

L-161982 is a selective EP4 receptor antagonist. L-161982 completely blocks PGE2-induced ERK phosphorylation and cell proliferation of HCA-7 cells. L-161982 alleviates collagen-induced arthritis in mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1471
CAS No.: 3801-06-7
Target:  

Carbonic Anhydrase

Research Areas:  

Inflammation/Immunology

Fluorometholone acetate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester. Fluorometholone acetate potently inhibits carbonic anhydrase (CA) with IC50s of 2.18 μM and 17.5 μM for hCA-I and hCA-II, respectively. Fluorometholone acetate has anti-inflammatory effect and has the potential for external ocular inflammation research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118716
CAS No.: 105650-23-5
Purity:  99.93%
Synonyms: 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) is the most abundant of generation of heterocyclic amines (HCA), resulted in the cooking of meat . DNA damaging and mutagenic activities. PhIP also has oestrogenic activity that could contribute to its tissue specific carcinogenicity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W015560
CAS No.: 99-10-5
3,5-Dihydroxybenzoic acid a potential biomarker for the consumption of many food products, including beer, nuts, peanut, and pulses. 3,5-Dihydroxybenzoic acid is the agonist for hydroxycarboxylic acid receptor 1 (HCA1, also known as GPR81) that inhibits lipolysis in adipocytes. 3,5-Dihydroxybenzoic acid is the competitive inhibitor for tyrosine phenol-lyase (TPL), exhibits an affinity of Ki=25.7 μM. 3,5-Dihydroxybenzoic acid is orally active .
loading...
    loading...
Cat. No.: HY-14857
CAS No.: 401904-75-4
Purity:  99.22%
Synonyms: HCA2969
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

Carotegrast (HCA2969) is an orally active α4 integrin inhibitor with anti-inflammatory activity. Carotegrast can be used in the research of inflammation-related diseases, such as ulcerative colitis .
loading...
    loading...
Cat. No.: HY-116141
CAS No.: 161180-11-6
Purity:  ≥98.0%
Synonyms: 7-HCA; Umbelliferyl Arachidonate; 7-HC-arachidonate
Target:  

Phospholipase MAGL

Research Areas:  

Others

7-Hydroxycoumarinyl arachidonate (7-HCA) is a fluorogenic substrate of cytosolic phospholipase A2 (PLA2). 7-Hydroxycoumarinyl arachidonate is also a fluorogenic substrate for monoacylglycerol lipase (MAGL). MAGL protein catalyzes the hydrolysis of 7-Hydroxycoumarinyl arachidonat to generate Arachidonic acid (AA) and the highly fluorescent 7-hydroxyl coumarin (7-HC; HY-N0573). Release of 7-HC can be measured using a fluorometer .
loading...
    loading...
Cat. No.: HY-100982
CAS No.: 24587-49-3
Purity:  ≥98.0%
Synonyms: trans-4-Hydroxycrotonic acid; trans-γ-Hydroxycrotonic acid; T‐HCA
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

(E)-4-Hydroxycrotonic acid (T-HCA) is a high-affinity ligand for GHB binding sites, with a ki value of 1.1 μM. The introduction of diaryl substituents into (E)-4-Hydroxycrotonic acid significantly enhances its affinity for GHB binding sites, with ki values ranging from 0.023 to 0.075 μM. (E)-4-Hydroxycrotonic acid holds promise for optimizing GHB ligand structures and assisting in the development of effective three-dimensional pharmacophore models .
loading...
    loading...
Cat. No.: HY-179026
HCA-6 is a calcium-channel and P-glycoprotein blocker. HCA-6 can induce cancer cells apoptosis and increase anticancer activity of Cisplatin (HY-17394). HCA-6 also exhibits antibacterial activity against Bacillus subtilis. HCA-6 can be used for the research of cancer and infection, such as breast cancer .
loading...
    loading...
Cat. No.: HY-147985
CAS No.: 2417232-26-7
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCA I-IN-1 (Compound 6q) is a human carbonic anhydrase I (hCA I) inhibitor with Ki values of 38.3, 716.4, 940.1 and 192.8 nM against hCA I, hCA II, hCAIX and hCAXII, respectively .
loading...
    loading...
Cat. No.: HY-147986
CAS No.: 2417232-12-1
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCA I-IN-2 (Compound 6d) is a selective human carbonic anhydrase I (hCA I) inhibitor with Ki values of 18.8, 375.1, 1721 and 283.9 nM against hCA I, hCA II, hCAIX and hCAXII, respectively .
loading...
    loading...
Cat. No.: HY-155391
CAS No.: 3032826-63-1
Purity:  99.96%
Research Areas:  

Cancer

hCA/Wnt/β-catenin-IN-1 (Compd 15) is an inhibitor of hCA (Ki: 33.6, 24.1, 6.8 nM for hCA II, hCA IX, hCA XII). hCA/Wnt/β-catenin-IN-1 reduces P-gp activity. hCA/Wnt/β-catenin-IN-1 also inhibits Wnt/β-catenin signaling pathway. hCA/Wnt/β-catenin-IN-1 inhibits cancer cell viability, including the NCI/ADR-RES DOX-resistant cell line .
loading...
    loading...
Cat. No.: HY-146206
CAS No.: 2389034-65-3
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

HCAIX-IN-1 (compound 21e) is a potent and selective HCAIX inhibitor with KIs of 694.9, 126.6, 3.3, 9.8 nM for hCA I, hCA II, hCA IX, hCA XII, respectively .
loading...
    loading...
Cat. No.: HY-152140
CAS No.: 952306-80-8
Purity:  99.41%
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCAII-IN-8, an amide, is a highly selective carbonic anhydrase (CA) inhibitor with an IC50 value of 0.18 μM against hCA II .
loading...
    loading...